Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jean C. Helmijr
LRG1 mRNA Expression in Breast Cancer Associates With PIK3CA Genotype and With Aromatase Inhibitor Therapy Outcome
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Somatic Mutation Detection Using Various Targeted Detection Assays in Paired Samples of Circulating Tumor DNA, Primary Tumor and Metastases From Patients Undergoing Resection of Colorectal Liver Metastases
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Related publications
Performance of FRAX in Women With Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry‐Based Cohort Study
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
Random-Start Ovarian Stimulation With Aromatase Inhibitor for Fertility Preservation in Women With Japanese Breast Cancer
Reproductive Medicine and Biology
Reproductive Medicine
Cell Biology
Sequential Changes in Gene Expression Profiles in Breast Cancers During Treatment With the Aromatase Inhibitor, Letrozole
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
PIK3CA Mutation Predicts Resistance to Breast Cancer Therapy
Cancer Discovery
Oncology
Comprehensive CYP2D6 Genotype and Adherence Affect Outcome in Breast Cancer Patients Treated With Tamoxifen Monotherapy
Breast Cancer Research and Treatment
Cancer Research
Oncology
Aromatase Inhibitor Associated Musculoskeletal Symptoms Are Associated With Reduced Physical Activity Among Breast Cancer Survivors
Breast Journal
Internal Medicine
Surgery
Oncology
PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor
Breast Care
Surgery
Oncology
A Polymorphism in the TC21 Promoter Associates With an Unfavorable Tamoxifen Treatment Outcome in Breast Cancer
Cancer Research
Cancer Research
Oncology
